Jay Shepard - 15 Jan 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Jay P. Shepard
Issuer symbol
INO
Transactions as of
15 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 15:06:22 UTC
Previous filing
04 Jun 2021
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +4,274 +33% 17,248 15 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -4,274 -50% $0.000000 4,273 15 Jan 2022 Common Stock 4,274 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on January 15, 2021; 4,274 shares vested on January 15, 2022; 4,273 shares will vest on January 15, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both